TME Pharma N.V. (EPA:ALTME)
0.1080
-0.0020 (-1.82%)
Aug 8, 2025, 11:45 AM CET
TME Pharma Revenue
In the year 2024, TME Pharma had annual revenue of 19.00K EUR with 11.76% growth. TME Pharma had revenue of 19.00K in the half year ending December 31, 2024.
Revenue
19.00K
Revenue Growth
+11.76%
P/S Ratio
544.88
Revenue / Employee
1.58K
Employees
12
Market Cap
10.35M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 19.00K | 2.00K | 11.76% |
Dec 31, 2023 | 17.00K | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | 33.00K | -2.00K | -5.71% |
Dec 31, 2020 | 35.00K | -119.00K | -77.27% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.74B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.76B |
ABIVAX Société Anonyme | 10.59M |
Virbac | 1.40B |